CGP-37849 is a competitive antagonist at the NMDA receptor. It is a potent orally active anticonvulsant in animal models and was researched for the treatment of epilepsy. It also has neuroprotective activity and shows antidepressant and anxiolytic effects.
This page contains content from the copyrighted Wikipedia article "CGP-37849"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
